𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ALPHA-INTERFERON AND PREGNANCY IN A PATIENT WITH CML

✍ Scribed by J. H. LIPTON; C. M. DERZKO; J. CURTIS


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
268 KB
Volume
14
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis


A 34-year-old woman on interferon for CML for 7 years, experienced problems with conception. Full work-up revealed a short luteal phase and therapy with clomiphene was initiated. Pregnancy occurred and a normal infant was delivered by C-section. The detailed infertility evaluation is described and the impact of interferon therapy on pregnancy is reviewed. Successful pregnancy appears possible in woman taking interferon on a chronic basis.


πŸ“œ SIMILAR VOLUMES


Hypertriglyceridemia may be severe in CM
✍ MarΓ­a JesΓΊs PeΓ±arrubia; Dr. Juan Luis Steegmann; Esperanza Lavilla; Felipe Casad πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 188 KB

We analyzed serum triglyceride (TG) levels in 22 chronic myeloid leukemia (CML) patients treated with interferon-a (IFN-a). Hypertriglyceridemia was present in one-half of patients at diagnosis, and IFN-a treatment was associated with a further increase in 90% of the total group of patients. This in

Interferon-alpha antibodies in patients
✍ Otto PrΓΌmmer; Delta-P Study Group πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 657 KB

Background. Prolonged therapy with interferon (IFN) may lead to the formation of IFN antibodies. Methods. Patients with renal cell carcinoma (n = 270) with advanced localized disease were randomized after complete tumor resection to receive treatment with adjuvant recombinant IFN-alpha-2a (rIFN-a2a

Hepatitis C genotypes in hemophilic pati
✍ Ms. Helen Devereux; Paul Telfer; Christine Lee; Geoffrey Dusheiko πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 462 KB

## Abstract The effect of α‐interferon on the hepatitis C genotypes was examined in 25 anti‐HCV‐positive hemophilic patients. The rate of multiple HCV genotypes in patients who are likely to have mixed infections was also studied. Pretreatment results showed that 3/25 (12%) patients had a change in